The FreeStyle Libre 3 Continuous Glucose Monitoring (FSL3) System is used to characterize the glycemic profiles of people with and without a prediabetes diagnosis.
This is a non-pivotal, non-randomized, multi-center, prospective, non-significant risk to evaluate the glycemic profiles of people with and without a prediabetes diagnosis using continuous glucose monitoring. Up to 2000 subjects will be enrolled in up to 20 sites. Approximately 50% of evaluable subjects will have a prediabetes diagnosis.
Study Type
OBSERVATIONAL
Enrollment
2,000
Abbott Sensor Based Glucose Monitoring System (FreeStyle Libre 3 System)
Diabetes and Obesity Care
Bend, Oregon, United States
RECRUITINGCharacterize the glycemic profiles of people with and without a prediabetes diagnosis.
This is a data collection study.
Time frame: up to 50 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.